Cargando…

Preliminary study on changes in BDNF in patients with depression after percutaneous coronary intervention

INTRODUCTION: Depression and coronary artery disease (CAD) are often comorbid conditions. The presence of depression significantly interferes with the recovery after CAD therapy intervention, such as percutaneous coronary intervention (PCI), one of the most common medical procedures in developed cou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Medved, S., Sović, S., Ganoci, L., Božina, N., Šagud, M., Bulum, J., Mihaljević-Peleš, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596015/ http://dx.doi.org/10.1192/j.eurpsy.2023.232

Ejemplares similares

The role of zinc, albumin, c reactive protein, and interleukin-6 in differentiation of unipolar depression and depression in bipolar disorder
por: Bagaric, T., et al.
Publicado: (2021)

“Flexible Assertive Community Mental Health Teams for the Treatment of Psychosis in Extraordinary Circumstances during Pandemics and Earthquakes 2020/2021: are we Flexible Enough?”
por: Rojnic Kuzman, M., et al.
Publicado: (2022)

SLC6A3, HTR2C and HTR6 Gene Polymorphisms and the Risk of Haloperidol-Induced Parkinsonism
por: Nedic Erjavec, Gordana, et al.
Publicado: (2022)

Plasma Brain-Derived Neurotrophic Factor Levels in First-Episode and Recurrent Major Depression and before and after Bright Light Therapy in Treatment-Resistant Depression
por: Kosanovic Rajacic, Biljana, et al.
Publicado: (2023)

Development of depression in patients hospitalized for COVID-19 infection
por: Lucijanić, D., et al.
Publicado: (2023)

Tinnitus as a comorbidity to depression and transcranial magnetic stimulation as a treatment for both - case report
por: Marinovic, P., et al.
Publicado: (2022)

Safety and efficacy of dual antiplatelet therapy after percutaneous coronary interventions in patients with end-stage liver disease
por: Ostojic, Zvonimir, et al.
Publicado: (2021)

UGT2B7 c.-161C>T Polymorphism Frequency in Croatian Population
por: Božina, Tamara, et al.
Publicado: (2023)

The Associations between COMT and MAO-B Genetic Variants with Negative Symptoms in Patients with Schizophrenia
por: Madzarac, Zoran, et al.
Publicado: (2021)

Evaluation of plasma levels of BDNF in patients with disorder depressive
por: Galletta, D., et al.
Publicado: (2021)

The relationship among psychopathology, religiosity, and nicotine dependence in Croatian war veterans with posttraumatic stress disorder
por: Šagud, Marina, et al.
Publicado: (2018)

QT Dispersion: Does It Change after Percutaneous Coronary Intervention?
por: Alasti, Mohammad, et al.
Publicado: (2011)

Effect of Lifestyle Changes after Percutaneous Coronary Intervention on Revascularization
por: Wang, Yang, et al.
Publicado: (2020)

Drug-drug-gene Interactions as Mediators of Adverse Drug Reactions to Diclofenac and Statins: A Case Report and Literature Review
por: Božina, Nada, et al.
Publicado: (2021)

Nicotine dependence in Croatian male inpatients with schizophrenia
por: Šagud, Marina, et al.
Publicado: (2018)

HTR1A, HTR1B, HTR2A, HTR2C and HTR6 Gene Polymorphisms and Extrapyramidal Side Effects in Haloperidol-Treated Patients with Schizophrenia
por: Grubor, Mirko, et al.
Publicado: (2020)

Use of pharmacogenomics in elderly patients treated for cardiovascular diseases
por: Božina, Nada, et al.
Publicado: (2020)

Depression and Anxiety in patients undergoing Percutaneous Coronary Intervention for Acute Coronary Syndrome
por: Mujtaba, Syed Fayaz, et al.
Publicado: (2020)

A Preliminary Real-Time and Realistic Simulation Environment for Percutaneous Coronary Intervention
por: Wu, Jianhuang, et al.
Publicado: (2015)

Risk Factors for Rivaroxaban-Related Bleeding Events—Possible Role of Pharmacogenetics: Case Series
por: Šimičević, Livija, et al.
Publicado: (2023)

Hemorrhagic complications during percutaneous coronary interventions: prospective analysis of 270 cases
por: Kanto, MCFS, et al.
Publicado: (2001)

Changes in Heart Rate Variability Parameters after Elective Percutaneous Coronary Intervention
por: Abrootan, Saeed, et al.
Publicado: (2015)

PS92. Serum BDNF and GDNF levels before and after the 12-week antidepressant treatments among outpatients with major depressive disorder
por: Lee, Bun-Hee, et al.
Publicado: (2016)

In stent restenosis after percutaneous coronary intervention
por: Eyüboğlu, Mehmet
Publicado: (2016)

Catechol-O-methyltransferase rs4680 and rs4818 haplotype association with treatment response to olanzapine in patients with schizophrenia
por: Nikolac Perkovic, Matea, et al.
Publicado: (2020)

Pre-existing depression in patients with coronary artery disease undergoing percutaneous coronary intervention
por: Park, Jangho, et al.
Publicado: (2021)

Increased prevalence of anxiety and depression symptoms in patients with coronary artery disease before and after percutaneous coronary intervention treatment
por: Gu, Guoqiang, et al.
Publicado: (2016)

Reduction in Planned Percutaneous Coronary Interventions After the Policy Change for Ischemia Assessment in Japan
por: Kanaoka, Koshiro, et al.
Publicado: (2023)

Assessing the Coronary Microcirculation in Patients After Primary Percutaneous Coronary Intervention
por: Yong, Andy S. C., et al.
Publicado: (2018)

Colchicine for symptomatic coronary artery disease after percutaneous coronary intervention
por: Aw, Kah Long, et al.
Publicado: (2022)

Preliminary findings on diagnostic validity of the ICD-11 personality disorder scales among Croatian psychiatric patients
por: Jaksic, N., et al.
Publicado: (2023)

PS120. Effects of linalool on chronic stress-induced depressive-like behaviour and BDNF protein in the hippocampus of rats
por: Saiyudthong, Somrudee, et al.
Publicado: (2016)

Postcardiac Injury Syndrome after Percutaneous Coronary Intervention
por: Park, Jin-Seok, et al.
Publicado: (2010)

Thrombotic Thrombocytopenic Purpura after Percutaneous Coronary Intervention
por: Lee, Jung-Min, et al.
Publicado: (2006)

Update on Antithrombotic Therapy after Percutaneous Coronary Intervention
por: Saito, Yuichi, et al.
Publicado: (2019)

Pharmacology before, during and after percutaneous coronary intervention
por: Zaman, Azfar G, et al.
Publicado: (2021)

PT647. Changes in BDNF methylation status before and after receiving Dialectical Behavior Therapy (DBT) in patients with borderline personality disorder
por: Wu, Shu-I, et al.
Publicado: (2016)

Prevalence and Clinical Significance of Discordant Changes in Fractional and Coronary Flow Reserve After Elective Percutaneous Coronary Intervention
por: Matsuda, Junji, et al.
Publicado: (2016)

BDNF and cognitive function in Alzheimer’s disease
por: Sidenkova, A.
Publicado: (2022)

Nursing interventions in depressed children with low serum levels of BDNF
por: Sun, Qingrong, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_heqbsh93alrdu62q7vsu1ui63n